rs142600079
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001083961.2(WDR62):c.4564G>A(p.Gly1522Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000876 in 1,597,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001083961.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR62 | NM_001083961.2 | c.4564G>A | p.Gly1522Arg | missense_variant | 32/32 | ENST00000401500.7 | NP_001077430.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR62 | ENST00000401500.7 | c.4564G>A | p.Gly1522Arg | missense_variant | 32/32 | 1 | NM_001083961.2 | ENSP00000384792.1 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000189 AC: 42AN: 222732Hom.: 0 AF XY: 0.000122 AC XY: 15AN XY: 122798
GnomAD4 exome AF: 0.0000443 AC: 64AN: 1445560Hom.: 0 Cov.: 34 AF XY: 0.0000348 AC XY: 25AN XY: 718836
GnomAD4 genome AF: 0.000499 AC: 76AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 07, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 17, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at